Inactive Instrument

Highlights AKOUOS

Equities

AKUS

US00973J1016

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Akouos, Inc. Announces Positive Initial Clinical Results from the Phase 1/2 AK-OTOF-101 Study	Jan. 23	CI
Lilly Wraps Up Acquisition of Akouos	22-12-01	MT
Eli Lilly and Company completed the acquisition of Akouos, Inc. from a group of shareholders.	22-11-30	CI
Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing	22-11-30	MT
Akouos Q3 Loss Narrows	22-11-14	MT
AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-14	AQ
Akouos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Eli Lilly to Acquire Genetic Medicine Developer Akouos for up to $610 Million	22-10-18	MT
Eli Lilly to Acquire Genetic Medicine Firm Akouos for Up to $610 Million	22-10-18	MT
Akouos Shares Soar on Takeover by Eli Lilly	22-10-18	DJ
ETF Preview: ETFs, Futures Climb Pre-Bell Ahead of Industrial Production Report	22-10-18	MT
Eli Lilly to buy gene therapy company Akouos for $487 mln	22-10-18	RE
Eli Lilly to Acquire Akouos, Developer of Hearing Loss Treatments, for Up to $610 Million	22-10-18	MT
Eli Lilly to Buy Akouos for Up to $610 Million	22-10-18	DJ
Eli Lilly Signs $610 Million Deal to Acquire US Biotech Akouos	22-10-18	MT
Eli Lilly and Company entered into a definitive agreement to acquire Akouos, Inc. from a group of shareholders for approximately $460 million.	22-10-17	CI
Akouos, Inc. Receives FDA Clearance of Its IND Application for AK-OTOF, A Gene Therapy Intended for the Treatment of OTOF-Mediated Hearing Loss	22-09-13	CI
AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
Akouos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Akouos, Inc. Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear At the American Society of Gene and Cell Therapy 25Th Annual Meeting	22-05-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AKOUOS

Equities

AKUS

US00973J1016

Highlights

Filters